Urothelial Cancer
📧 Sign up to get email alerts when something new happens for Urothelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-17Clinical Trial Update: N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer [Phase 1]
A phase 1 trial evaluating N-803 in combination with pembrolizumab and enfortumab vedotin for urothelial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: A Study of MFA-370 in Patients with Metastatic Urothelial Cancer [Phase 1, Phase 2]
A clinical trial evaluating MFA-370 in metastatic urothelial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
-
CLINICAL_TRIALS withdrawal · 2014-01-29Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]
This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for …
-
CLINICAL_TRIALS withdrawal · 2013-01-17Clinical Trial Update: Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer [Phase 2]
A Phase 2 trial of lapatinib plus weekly paclitaxel for advanced urothelial cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.